Title
Pain Management After Elective Shoulder Surgery
Pain Management After Elective Shoulder Surgery: A Randomized Quantitative Study Comparing Hydromorphone With Piritramide
Phase
Phase 4Study Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Postoperative PainIntervention/Treatment
Hydromorphone Hcl 4Mg Tab Piritramide 15mg s.c.Study Participants
48Postoperative pain management plays an important role in elective shoulder surgery. The aim of this randomized quantitative study is to compare two frequently used postoperative pain regimes (hydromorphone versus piritramide) regarding onset and duration after the effectiveness of the single-shot interscalene block has diminished.
Hydal retard 4Mg Tab 2 times after surgery as basic medication. Hydal retard 2.6Mg maximum 2 per 24h when NRS > 5.
Dipidolor 15mg s.c. 2 times after surgery as basic medication. Dipidolor 7.5mg s.c. maximum 2 per 24h when NRS > 5.
Hydromorphone Hcl 4 milligram (mg) Tab 2 times after surgery as basic medication. Hydromorphone Hcl 2.6mg maximum 2 per 24h when numeric rating scale (NRS) > 5.
Piritramide 15mg s.c. 2 times after surgery as basic medication. Piritramide 7.5mg s.c. maximum 2 per 24h when numeric rating scale (NRS) > 5.
Inclusion Criteria: all patients undergoing elective shoulder surgery with a single-shot interscalene plexus brachialis block in addition to general anesthesia patients aged 18-99 years patients being capable of giving an informed consent to participation in this study Exclusion Criteria: patients aged below 18 years patients with decompensated liver, heart or renal insufficiency patients with any kind of lung disease patients with a chronic pain syndrome patients with a previous pain medication with more than 3 drugs over more than 3 months